96.16
-1.98
(-2.02%)
At close: January 10 at 4:00:02 PM EST
95.00
-1.16
(-1.21%)
After hours: January 10 at 4:04:34 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 7 | 9 | 9 |
| Avg. Estimate | 0.82 | 0.83 | 3.35 | 3.72 |
| Low Estimate | 0.81 | 0.79 | 3.34 | 3.51 |
| High Estimate | 0.83 | 0.88 | 3.36 | 3.8 |
| Year Ago EPS | 0.81 | 0.77 | 3.01 | 3.35 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 8 | 10 | 10 |
| Avg. Estimate | 346.76M | 352.18M | 1.35B | 1.47B |
| Low Estimate | 344.78M | 345M | 1.35B | 1.46B |
| High Estimate | 348.5M | 358.73M | 1.35B | 1.48B |
| Year Ago Sales | 324.51M | 323.51M | 1.26B | 1.35B |
| Sales Growth (year/est) | 6.85% | 8.86% | 7.22% | 9.06% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.77 | 0.72 | 0.87 | 0.8 |
| EPS Actual | 0.81 | 0.77 | 0.92 | 0.86 |
| Difference | 0.04 | 0.05 | 0.05 | 0.06 |
| Surprise % | 5.71% | 7.69% | 5.26% | 7.77% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.82 | 0.83 | 3.35 | 3.72 |
| 7 Days Ago | 0.82 | 0.83 | 3.35 | 3.71 |
| 30 Days Ago | 0.82 | 0.82 | 3.35 | 3.71 |
| 60 Days Ago | 0.82 | 0.82 | 3.35 | 3.71 |
| 90 Days Ago | 0.84 | 0.82 | 3.31 | 3.69 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 6 | 1 |
| Up Last 30 Days | 1 | 2 | 6 | 1 |
| Down Last 7 Days | 3 | 2 | -- | -- |
| Down Last 30 Days | 3 | 2 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MMSI | 1.51% | 7.42% | 11.41% | 10.87% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | Raymond James: Outperform to Outperform | 12/31/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 12/23/2024 |
| Upgrade | Wells Fargo: Equal-Weight to Overweight | 12/11/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 12/9/2024 |
| Reiterates | Needham: Buy to Buy | 10/31/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 10/31/2024 |
Related Tickers
ICUI ICU Medical, Inc.
154.35
-4.12%
ATRC AtriCure, Inc.
31.41
-6.68%
HAE Haemonetics Corporation
76.67
-1.83%
TFX Teleflex Incorporated
174.61
-1.88%
COO The Cooper Companies, Inc.
90.31
-1.71%
LMAT LeMaitre Vascular, Inc.
93.59
-1.38%
WST West Pharmaceutical Services, Inc.
331.73
-1.54%
UTMD Utah Medical Products, Inc.
60.91
-0.02%
STVN Stevanato Group S.p.A.
22.94
-4.18%
NVST Envista Holdings Corporation
18.58
-3.08%